External Facilitation to Increase Prescribing of AUD Medications in the Psychiatric Setting
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorUniversity of Maryland, Baltimore
About this trial
This project will pilot test an implementation facilitation intervention to increase prescribing of medications for alcohol use disorder (MAUD) in patients with major mental illness and alcohol use disorder in three psychiatry treatment clinics.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
For prescribers: working as a prescriber, non-prescribing clinician, or administrator at one of the three participating clinics.
For patients: has major mental illness (major depressive disorders, bipolar disorder, schizophrenia spectrum disorders, other psychotic disorders; posttraumatic stress disorder)
For patients: has Alcohol Use Disorder and is being treated in one of the three participating clinics.
Disqualifiers
For all: age is less than 18 years old
For all: not able to complete informed consent
Trial design
Design model
Single group
Treatments tested in this trial
Implementation Facilitation
Other interventionImplementation facilitation is a multi-faceted process of enabling and supporting the adoption and integration of best practices into routine clinical care. It involves collaboration to understand a setting's challenges and barriers and working together to identify the best activities to address them. IF will incorporate External Facilitation, a problem-solving implementation strategy that builds supportive interpersonal relationships between an External Facilitator who is outside of the clinic who works with clinics and their identified internal champions to learn their unique barriers to implementation, use strategies to address these barriers, and plan for sustainability by integrating the practice into routine processes and workflows. Other implementation activities that will be used IF include staff training, patient education, audit and feedback, and care coordination.
Treatment groups
40 Participants
are divided into 1 treatment groupGroup A: Implementation FacilitationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Prescribing medications for alcohol use disorder
Change in the proportion of eligible patients prescribed a medication for alcohol use disorder in the clinic
Time frame
6 months after the end of implementation facilitationSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov